US backs OpenAI fair use & Google avoids ad-tech breakup - Tech News (Sep 3, 2026)
DOJ backs OpenAI, Google avoids an ad-tech breakup, new AI models arrive, and brain-engineering trials begin. Listen to today's tech briefing.
Our Sponsors
Today's Tech News Topics
-
US backs OpenAI fair use
— The Justice Department backed OpenAI in the New York Times lawsuit, arguing AI training on copyrighted material can qualify as fair use. The move raises the stakes for copyright law, AI training data, and publisher licensing. -
Google avoids ad-tech breakup
— A federal judge found Google violated antitrust law in ad tech but did not force a breakup. The ruling keeps pressure on Google's advertising business while leaving the biggest remedy fight for later. -
Meta Google race on AI
— Meta launched Muse Spark 1.3, Google released Gemini 3.8 Flash and Flash Cyber, and OpenAI shared more about GPT-Live. The theme is clear: faster AI, specialized models, voice interfaces, and tougher competition among frontier labs. -
Security deal and dark web IDs
— Palo Alto Networks agreed to buy Console for about $500 million, adding to the push toward AI automation in enterprise security. Separately, the FBI is investigating reports that scans of 153 million driver's licenses were listed on a dark web marketplace, raising identity theft and fraud concerns. -
Broadcom pressure and Uber layoffs
— Broadcom warned of pressure in its AI chip business, a notable signal for semiconductor and data center investors. Uber also cut more than 3,000 jobs, showing that cost discipline and restructuring remain active themes across tech. -
NYC restricts classroom generative AI
— New York City announced a one-year ban on student use of generative AI through eighth grade while adding AI literacy for high school students. The policy could influence education technology rules far beyond the city's schools. -
Brain-control therapy enters trials
— First human trials are beginning for chemogenetics, a technique designed to switch specific neurons on or off using a drug. Early work in epilepsy, Parkinson's disease, and pain highlights the growing reach of neurotechnology and precision brain therapies.
Sources & Tech News References
- → US government backs OpenAI in New York Times copyright lawsuit
- → Court rules Google violated ad-tech antitrust law but will not be forced to sell its ad exchange
- → OpenAI publishes engineering deep dive on GPT-Live voice interface
- → Meta releases Muse Spark 1.3 model
- → Google launches Gemini 3.8 Flash and Cyber variant
- → Broadcom says AI chip growth is under pressure and fourth-quarter guidance misses expectations
- → Palo Alto Networks acquires Console for about $500 million
- → Uber announces layoffs of more than 3,000 employees
- → NYC public schools ban generative AI use through eighth grade
- → FBI investigates report of 153 million driver’s licenses exposed on dark web marketplace
- → Meta reportedly changes AI performance metrics and removes token-usage target
- → Kimi API adds native support for Codex and Claude Code
- → Parloa Guide: How CIOs Can Cross the AI Divide
- → Parloa Promotes AI Customer Service Platform on Contact Sales Page
- → Google Launches Gemini 3.8 Flash and Flash Cyber
- → Chemogenetics Enters Human Trials
- → GitHub Explains How It Cuts Copilot Costs Without Hurting Quality
- → AI Raises the Ceiling, Not Just Productivity
- → Judge Orders Changes to Google’s Ad-Tech Business
- → How to Protect Yourself from Workslop
- → Making the Internet Boring
- → AI Agents Email Bruce Schneier About Security Barriers
- → Exo: Recursive Self-Improving AI Agent Harness
- → What Tech Workers Plan To Do After Leaving the Industry
- → Justice Department Backs OpenAI in New York Times Copyright Fight
Full Episode Transcript: US backs OpenAI fair use & Google avoids ad-tech breakup
Imagine a treatment that can quiet a tiny set of brain cells with a pill after those cells have been specially prepared. That idea is now entering human trials. Welcome to The Automated Daily, tech news edition. The podcast created by generative AI. It's September 3rd, 2026. I'm TrendTeller, and here are the tech stories worth your time today.
US backs OpenAI fair use
First, one of the most important AI court fights just got a major political signal. The US Justice Department filed in support of OpenAI in the New York Times copyright case, saying that training large AI models on copyrighted material can qualify as fair use. It does not settle the lawsuit, but it shows Washington sees broad AI training rights as strategically important. If that view holds up in court, it could reshape how AI companies collect training data and how publishers negotiate from here.
Google avoids ad-tech breakup
In the model race, the pace is still intense. Meta launched Muse Spark 1.3 and says it is the company's strongest AI model so far, with a clear push toward more capable personal agents. Google officially released Gemini 3.8 Flash and a security-focused Flash Cyber variant, signaling a strategy that pairs general-purpose AI with more specialized tools. OpenAI also shared more detail on GPT-Live, its stateful voice interface, highlighting a wider shift in the market: labs are now competing not just on model quality, but on speed, voice interaction, and usefulness in live products. Meta is also reportedly moving away from token usage as a key internal AI metric, another sign that the industry is focusing less on raw volume and more on outcomes.
Meta Google race on AI
Google also had a major day in court. A federal judge found the company violated antitrust law in ad tech, but stopped short of forcing it to sell off its ad exchange business. That makes this an important legal loss for Google without the most dramatic structural consequence regulators wanted. Even so, the case matters because ad tech remains one of Google's most valuable businesses, and the next phase will be all about what remedies competitors and regulators pursue.
Security deal and dark web IDs
On the security front, Palo Alto Networks is buying automation startup Console for roughly half a billion dollars. The acquisition points to a larger trend: big cybersecurity firms want more AI-driven automation inside their platforms, especially for IT and operations work that is repetitive and expensive. In a separate and much more worrying development, the FBI says it is investigating a report that digital scans of more than 153 million driver's licenses from the US and Canada were found for sale on a dark web marketplace. If confirmed, that would be one of the largest identity document exposures in recent memory, with obvious implications for fraud, impersonation, and consumer security.
Broadcom pressure and Uber layoffs
Two business stories suggest the market is watching the AI economy with a slightly more cautious mood. Broadcom said its AI chip business is facing growth pressure, and its outlook came in below expectations. Because Broadcom is deeply tied into AI infrastructure, investors tend to read its numbers as an early signal for spending across the sector. And Uber is cutting more than 3,000 jobs, about 10 percent of its global workforce, as it simplifies management layers and keeps a close eye on efficiency. Together, those stories show that even in an AI-heavy year, cost discipline is still very much the rule.
NYC restricts classroom generative AI
In education, New York City is taking a stricter approach to generative AI. Officials announced a one-year ban on student use of generative AI from pre-K through eighth grade, while also introducing AI literacy lessons for high school students. That mix is notable: younger students get tighter limits, older ones get more structured exposure. Because New York runs one of the largest school systems in the United States, the policy could become a template for other districts deciding how fast, or how carefully, to bring AI into the classroom.
Brain-control therapy enters trials
And finally, the science story. Early human trials are beginning for chemogenetics, a technique that aims to control specific brain cells with a drug after those cells have been specially engineered. The first conditions being studied include epilepsy, Parkinson's disease, and chronic pain, with severe epilepsy looking like the most realistic near-term use. This is still an invasive and imperfect approach, so it is far from everyday medicine. But it is a striking sign of where neurotechnology is heading: away from broadly affecting the brain and toward much more precise control.
That's the briefing for September 3rd, 2026. If you want a clear roundup of the stories shaping tech, come back tomorrow. I'm TrendTeller, and this was The Automated Daily, tech news edition.
More from Tech News
- August 31, 2026 AI agents hide their tracks & Cloud giants buy more compute
- August 30, 2026 EU AI transparency rules begin & OpenAI Astra research breakthrough
- August 29, 2026 AI deal faces EU scrutiny & Open models and video AI
- August 28, 2026 OpenAI funding, chips, and safety & Nvidia expands infrastructure lead
- August 27, 2026 AI compute spending accelerates & OpenAI explains agent breach